DARLING INGREDIENTS INC.
DAR
$57.89
+2.41%
Darling Ingredients Inc. develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. As a global leader in rendering and recycling, the company operates through three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients, with a distinct competitive edge in the circular economy. The current investor narrative centers on the company's revenue growth acceleration, driven by strong demand in Feed Ingredients and expanding renewable fuel opportunities, while margins remain under pressure from cost inflation and operational challenges. Recent quarterly results showed a 20.6% YoY revenue increase, but net income volatility and a high trailing PE have sparked debate about earnings sustainability.…
DAR
DARLING INGREDIENTS INC.
$57.89
Investment Opinion: Should I buy DAR Today?
Rating: Hold. Darling Ingredients is a cyclical turnaround play with strong revenue momentum but compressed margins. The single analyst's EPS estimate of $5.15 implies a forward PE of 11.1x, which is attractive, but the trailing PE of 94.1x and margin deterioration warrant caution.
Supporting Evidence: Revenue grew 20.6% YoY in Q4 2025, accelerating from prior quarters. Free cash flow of $679M TTM provides a solid cash cushion. The PS ratio of 0.97x is low, reflecting the low-margin business model. However, gross margin fell 660 bps YoY to 16.9%, and net margin is only 1.0%. The EV/EBITDA of 12.7x is moderate. Without industry average data, the forward PE of 11.1x appears reasonable for a company with accelerating revenue.
Risks & Conditions: The Hold rating would upgrade to Buy if gross margins stabilize above 20% and revenue growth continues above 15%. It would downgrade to Sell if revenue growth decelerates below 10% or margins compress further. The biggest risks are cost inflation and earnings disappointment. Overall, the stock appears fairly valued on forward earnings but overvalued on trailing earnings, making it a hold until margin trends improve.
Sign up to view all
DAR 12-Month Price Forecast
Darling Ingredients is at a crossroads: revenue growth is strong and forward valuation is reasonable, but margin compression and high trailing PE create risk. The base case of continued growth with stable margins is most likely (45% probability), but the bull and bear cases are balanced. The stock's recent pullback from highs may offer an entry point, but investors should wait for evidence of margin stabilization. Upgrade to bullish if gross margins recover above 20%; downgrade to bearish if revenue growth falls below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DARLING INGREDIENTS INC.'s 12-month outlook, with a consensus price target around $75.26 and implied upside of +30.0% versus the current price.
Average Target
$75.26
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$46 - $75
Analyst target range
Only 1 analyst covers the stock, with an estimated EPS average of $5.15 for the current fiscal year. The consensus recommendation is not explicitly provided, but the single analyst's estimates imply a bullish outlook. The average target price is not available, but the estimated EPS of $5.15 suggests a forward PE of 11.0x at the current price of $56.53. The low EPS estimate is $4.90 and the high is $5.33, indicating a relatively narrow range. The implied upside based on forward PE is not calculable without a target price, but the low forward PE suggests potential upside if earnings materialize. The limited analyst coverage (1 analyst) indicates that DAR is a mid-cap stock with less institutional attention, which can lead to higher volatility and less efficient price discovery. The lack of a consensus recommendation and target price means investors must rely on their own analysis. The narrow EPS range suggests some confidence in the earnings recovery, but the single data point limits the robustness of the outlook.
Bulls vs Bears: DAR Investment Factors
Darling Ingredients presents a classic turnaround story: revenue is accelerating strongly (20.6% YoY), free cash flow is robust ($679M), and the forward PE of 11.1x is attractive if earnings materialize. However, the trailing PE of 94.1x, gross margin compression from 23.5% to 16.9%, and low ROE of 1.3% highlight significant near-term risks. The bull case hinges on sustained revenue growth and margin recovery, while the bear case focuses on cost pressures and high valuation multiples. Currently, the evidence slightly favors the bull case given the revenue momentum and low forward PE, but the margin trend is the critical swing factor.
Bullish
- Revenue Growth Accelerating: Q4 2025 revenue grew 20.6% YoY to $1.71B, accelerating from 10.0% in Q3 and 1.8% in Q2. This trend suggests strong demand across Feed and Food Ingredients segments.
- Low Forward PE of 11.1x: With estimated EPS of $5.15, the forward PE is 11.1x, which is reasonable for a company with accelerating revenue and positive free cash flow. This implies significant earnings recovery is priced in but not excessive.
- Strong Free Cash Flow Generation: TTM free cash flow is $679M, providing ample cushion for debt service and investments. This supports the balance sheet and reduces financial risk despite moderate leverage.
- Positive Net Income Turnaround: Net income swung from -$26.2M in Q1 2025 to $56.9M in Q4 2025, demonstrating operational improvement. The company is profitable on a TTM basis.
Bearish
- Trailing PE of 94.1x Is Extreme: The trailing PE is 94.1x, near the high end of its historical range (10.1x-123.1x). This reflects depressed current earnings and high market expectations for a rebound, leaving little room for error.
- Gross Margin Compression: Gross margin fell from 23.5% in Q4 2024 to 16.9% in Q4 2025, a 660 bps decline. Cost inflation and operational challenges are squeezing profitability.
- Low ROE of 1.3%: Return on equity is just 1.3%, indicating the company is generating minimal profit relative to shareholder equity. This raises questions about capital allocation efficiency.
- Limited Analyst Coverage: Only 1 analyst covers the stock, leading to less efficient price discovery and higher volatility. The lack of consensus targets increases uncertainty.
DAR Technical Analysis
The stock is in a strong uptrend over the past year, with a 1-year price change of +44.1%, significantly outperforming the S&P 500's 19.1% gain. Currently trading at $56.53, it sits at 85.6% of its 52-week range (low $29.15, high $66.02), indicating the stock is near the upper end of its range but not at overbought extremes. This positioning suggests momentum is intact but may face resistance near the 52-week high. Short-term momentum has diverged from the longer-term trend: the 1-month change is -6.3% and the 3-month change is -12.6%, both negative, contrasting with the strong 1-year performance. This divergence could signal a temporary pullback or consolidation phase, as the stock corrects from its March highs. The relative strength versus the S&P 500 over 1 month is -5.1%, confirming recent underperformance. The 52-week high of $66.02 represents key resistance; a breakout above this level would signal renewed bullish momentum and potential for further upside. The 52-week low of $29.15 provides strong support, and a breakdown below this level would be a bearish signal. Beta is 1.039, indicating the stock moves roughly in line with the market, with slightly higher volatility. The current pullback from the highs may offer a buying opportunity if support holds.
Beta
1.04
1.04x market volatility
Max Drawdown
-24.6%
Largest decline past year
52-Week Range
$29-$66
Price range past year
Annual Return
+46.7%
Cumulative gain past year
| Period | DAR Return | S&P 500 |
|---|---|---|
| 1m | -2.6% | +1.9% |
| 3m | -8.8% | +14.0% |
| 6m | +57.3% | +8.9% |
| 1y | +46.7% | +20.1% |
| ytd | +53.8% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DAR Fundamental Analysis
Revenue has shown strong growth, with the most recent quarter (Q4 2025) reporting $1.71 billion, up 20.6% YoY from $1.42 billion in Q4 2024. The multi-quarter trend is accelerating: Q3 2025 revenue was $1.56 billion (up 10.0% YoY), Q2 2025 was $1.48 billion (up 1.8% YoY), and Q1 2025 was $1.38 billion (down 2.8% YoY). The Feed Ingredients segment drove growth with $1.13 billion in revenue, while Food Ingredients contributed $429 million and Fuel Ingredients $153 million. The revenue acceleration is a positive signal, suggesting strong demand for animal by-products and renewable feedstocks. Profitability remains mixed: net income in Q4 2025 was $56.9 million, up sharply from $10.2 million in Q4 2024, but gross margin compressed to 16.9% from 23.5% a year ago. Operating margin was 8.1%, down from 8.6% in Q4 2024, indicating cost pressures. The company is profitable, but margin compression is a concern, especially given the high trailing PE. The balance sheet is moderately leveraged: debt-to-equity is 0.88, and the current ratio is 1.50, indicating adequate liquidity. Free cash flow (TTM) is $679 million, providing a solid cushion for debt service and investments. ROE is low at 1.3%, reflecting the thin net margins, but the company generates positive free cash flow, reducing financial risk.
Quarterly Revenue
$1.7B
2026-01
Revenue YoY Growth
+0.20%
YoY Comparison
Gross Margin
+0.16%
Latest Quarter
Free Cash Flow
$679230000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DAR Overvalued?
Since net income is positive ($56.9 million in Q4 2025), the primary valuation metric is the PE ratio. The trailing PE is 94.1x, while the forward PE is 11.1x, implying the market expects a sharp earnings recovery. The wide gap suggests that current earnings are depressed and the market is pricing in a significant rebound. The PS ratio is 0.97x, which is low for a packaged foods company, but this reflects the low-margin nature of the business. Compared to the industry average (not provided), the trailing PE of 94.1x appears extremely high, but the forward PE of 11.1x is more reasonable. The EV/EBITDA of 12.7x is moderate. Historically, the trailing PE has ranged from 10.1x (Q2 2023) to 123.1x (Q2 2025), and the current 94.1x is near the high end of that range, indicating that the market is pricing in optimistic future earnings. The PB ratio of 1.26x is near the lower end of its historical range (1.12x to 3.92x), suggesting the stock is not overvalued on a book value basis. Overall, the valuation is stretched on trailing earnings but appears reasonable on forward estimates, implying high expectations for a turnaround.
PE
95.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -49x~123x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Darling's debt-to-equity of 0.88 is moderate, but interest expense of $55.5M in Q4 2025 consumes a significant portion of operating income ($137.7M). Gross margin compression from 23.5% to 16.9% YoY indicates cost inflation and operational inefficiencies. Net margin is only 1.0% TTM, leaving little buffer for further cost increases. The company's low ROE of 1.3% suggests capital is not being deployed efficiently, and the high trailing PE of 94.1x means any earnings miss could trigger a sharp valuation reset.
Market & Competitive Risks: The stock's beta of 1.039 indicates slightly above-market volatility, making it sensitive to macro shifts. The 1-month relative strength of -5.1% vs. S&P 500 shows recent underperformance. As a mid-cap with only one analyst covering, the stock may face liquidity and information asymmetry risks. Regulatory changes in renewable fuel mandates could impact the Fuel Ingredients segment, which contributed $153M in Q4 revenue. Competitive pressure from other rendering and recycling firms could compress margins further.
Worst-Case Scenario: If margin compression persists and revenue growth decelerates, earnings could disappoint, causing the stock to fall to its 52-week low of $29.15. From the current price of $56.53, this represents a potential loss of -48.4%. Additionally, if the forward PE of 11.1x proves optimistic and actual EPS falls short of $5.15, the stock could re-rate lower. The historical max drawdown of -24.6% provides a more moderate downside reference, but the 52-week low scenario is realistic given the high trailing PE.
FAQ
The key risks are: 1) Margin compression – gross margin fell 660 bps YoY to 16.9%, and further declines could pressure earnings. 2) High trailing PE of 94.1x – any earnings miss could trigger a sharp sell-off. 3) Limited analyst coverage (only 1 analyst) leads to less efficient price discovery and higher volatility. 4) Macro sensitivity – beta of 1.039 means the stock moves with the market, and a recession could reduce demand for animal by-products. The most severe risk is a -48.4% decline to the 52-week low of $29.15 if earnings disappoint.
The 12-month forecast is mixed: the bull case (30% probability) sees the stock reaching $66-$75, driven by sustained revenue growth and margin recovery. The base case (45% probability) expects the stock to trade between $56 and $66 as earnings meet estimates. The bear case (25% probability) sees the stock falling to $40-$50 if growth decelerates and margins compress. The most likely scenario is the base case, assuming revenue growth moderates to 10-15% and margins stabilize. The single analyst's EPS estimate of $5.15 supports the base case.
DAR appears overvalued on trailing earnings (PE 94.1x) but undervalued on forward earnings (PE 11.1x). The PS ratio of 0.97x is low, reflecting the low-margin business. Compared to its historical PE range of 10.1x to 123.1x, the current trailing PE is near the high end, suggesting the market is pricing in optimistic future earnings. The PB ratio of 1.26x is near the low end of its historical range (1.12x-3.92x), indicating the stock is not overvalued on book value. Overall, the valuation is stretched on current earnings but reasonable if the earnings recovery occurs.
DAR is a speculative buy for investors who believe the earnings recovery will materialize. The forward PE of 11.1x based on estimated EPS of $5.15 is attractive, but the trailing PE of 94.1x indicates high risk. The stock has strong revenue momentum (20.6% YoY growth) and solid free cash flow ($679M TTM), but gross margin compression from 23.5% to 16.9% is a major concern. For risk-tolerant investors with a 12-month horizon, it could be a good buy if margins stabilize; for conservative investors, it's better to wait for evidence of margin recovery.
DAR is more suitable for short-to-medium-term investment (12-24 months) given its cyclical nature and current turnaround phase. The stock's beta of 1.039 indicates moderate volatility, and the recent 1-month decline of -6.3% suggests short-term weakness. Long-term investors may benefit if the company successfully expands margins and grows earnings, but the low ROE of 1.3% and high trailing PE are concerns. A minimum holding period of 12 months is recommended to allow the earnings recovery to play out. The stock pays no dividend, so total return depends on price appreciation.